CONTINUE TO SITE
OR WAIT null SECS
- Advertise
- Editorial Info
- Contact Us
- Terms & Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Formulary Watch. All rights reserved.
FDA Pipeline preview, May 2008
Recent FDA action (through May 2008) related to ceftobiprole, sugammadex, romiplostim, Gardasil, and amrubicin.
Approvable designation
Recommended for approval
Priority review
Orphan drug designation